Výsledky vyhledávání - "H. J. F. van Hoogstraten"

Efficacy and safety of infliximab as continuous or intermittent therapy in patients with moderate-to-severe plaque psoriasis: results of a randomized, long-term extension trial (RESTORE2)

Autor: Laurence Flint, Kristian Reich, Gottfried Wozel, Jonathan Barker, Hanzhe Zheng, H. J. F. van Hoogstraten

Publikováno v: British Journal of Dermatology. 168:1325-1334

SummaryBackground Continuous maintenance therapy with infliximab 5 mg kg−1 every 8 weeks is effective for moderate-to-severe plaque-type psoriasis. Objectives To evaluate the efficacy and safety of continuous vs. intermittent infliximab maintenance

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe3f560ec930d8ba6ec95c846c08cbcb
https://doi.org/10.1111/bjd.12404

Zobrazit plný text záznamu

Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1)

Autor: Kristian Reich, Hanzhe Zheng, Ortonne Jp, H. J. F. van Hoogstraten, Jonathan Barker, Gottfried Wozel, Maurice Hoffmann

Publikováno v: British Journal of Dermatology. 165:1109-1117

Summary Background Infliximab is indicated for treatment of moderate-to-severe plaque psoriasis in adults whose disease cannot be controlled with other systemic therapies, including methotrexate (MTX). To date, no studies have directly compared the e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e59dc505a9cae2aa8a18de584fbb6d2a
https://doi.org/10.1111/j.1365-2133.2011.10615.x

Zobrazit plný text záznamu

Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study

Autor: P Griffioen, H. J. F. Van Hoogstraten, J. van Hattum, W. Van Steenbergen, G. P. van Berge Henegouwen, G. J. Boland, H.R. van Buuren, Wim C. J. Hop, S.W. Schalm, Frank P. Vleggaar

Publikováno v: American Journal of Gastroenterology, 95(8), 2015-2022. Springer Nature

OBJECTIVE PSC has characteristics of an (auto)immune-mediated disease: however, few studies have evaluated corticosteroid therapy for this disorder. METHODS We performed an 8-wk double-blind randomized pilot study to assess the effects of additional

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0594a0ecfc1bea1aab01fff8fec1e474
https://hdl.handle.net/1765/56573

Zobrazit plný text záznamu

A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10 mg/kg or 20 mg/kg

Autor: R. Zwertbroek, Leopold G.J.B. Engels, H.R. van Buuren, M. B. M. De Smet, Willem Renooij, S.W. Schalm, J. G. S. Breed, H. J. F. Van Hoogstraten, G. P. van Berge Henegouwen, M. C. M. Rijk, Adelbert M. Smit, Wim C. J. Hop, J.W. den Ouden-Muller

Publikováno v: Alimentary Pharmacology & Therapeutics. 12:965-971

Background: Ursodeoxycholic acid (UDCA) prolongs transplantation-free survival in primary biliary cirrhosis (PBC). However, the optimal therapeutic dose has not been established. Aim: To compare the effects of UDCA administered in daily doses of 10 v

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3b24789790135203f6ff770ba787cf68
https://doi.org/10.1046/j.1365-2036.1998.00395.x

Zobrazit plný text záznamu

Plný text ve formátu HTML

The unusual patient with advanced renal insufficiency on ACE inhibitors

Autor: H. J. F. van Hoogstraten, J. van der Meulen, J. P. van der Sluijs

Publikováno v: Nephrology Dialysis Transplantation. 15:130-130

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1b801173164697994cfca413d1dff70d
https://doi.org/10.1093/ndt/15.1.130

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání